Infliximab is the Conventional Trick for Ulcerative Colitis as a Novel Therapeutic Option Against SARS-CoV-2 Infection (Letter)

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

KEIKHA MASOUD

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: International Journal of Infection Year:2020 | Volume:7 | Issue:4 Page(s): 0-0

Download Full-Text

View:

102

Download:

Cites:

Information Journal Paper

Title

Infliximab is the Conventional Trick for Ulcerative Colitis as a Novel Therapeutic Option Against SARS-CoV-2 Infection (Letter)

Author(s)

KEIKHA MASOUD | Issue Writer Certificate

Keywords

Infliximab

COVID

SARS

CoV

Abstract

Dear Editor,

Multimedia

No record.

Cites

No record.

References

What is the efficacy of BCG vaccination in the protection from COVID-19 in European countries?
A systematic review and meta-analysis of outcomes of infection with Helicobacter pylori dupA+ strains in Iranian patients
Infliximab clinically treating ulcerative colitis: A systematic review and meta-analysis
On the Alert for Cytokine Storm: Immunopathology in COVID-19
Pediatric Crohn Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated With Infliximab
Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure-a cautionary case series
Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: a stone for two birds
COVID-19 and immunomodulation in IBD

Cite

APA: Copy

KEIKHA, MASOUD. (2020). Infliximab is the Conventional Trick for Ulcerative Colitis as a Novel Therapeutic Option Against SARS-CoV-2 Infection (Letter). INTERNATIONAL JOURNAL OF INFECTION, 7(4), 0-0. SID. https://sid.ir/paper/709802/en

Vancouver: Copy

KEIKHA MASOUD. Infliximab is the Conventional Trick for Ulcerative Colitis as a Novel Therapeutic Option Against SARS-CoV-2 Infection (Letter). INTERNATIONAL JOURNAL OF INFECTION[Internet]. 2020;7(4):0-0. Available from: https://sid.ir/paper/709802/en

IEEE: Copy

MASOUD KEIKHA, “Infliximab is the Conventional Trick for Ulcerative Colitis as a Novel Therapeutic Option Against SARS-CoV-2 Infection (Letter),” INTERNATIONAL JOURNAL OF INFECTION, vol. 7, no. 4, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/709802/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops